UNCTAD Report Sees Sustainable African Growth In IP Flexibilities 15/06/2012 by William New, Intellectual Property Watch 1 Comment The United Nations agency on trade and development this week published its Economic Development in Africa 2012 report, which argued, among other things, that the region’s sustainable future depends on using flexibilities in intellectual property rights as appropriate.
Upcoming Event: 5th Product And Pipeline Enhancement For Generics 06/06/2012 by Intellectual Property Watch Leave a Comment A conference entitled the “5th Product and Pipeline Enhancement for Generics” to be held in Washington, DC on 17-19 July will feature industry leaders in the generic, branded pharmaceutical and API industries. Issues covered will include current and upcoming changes in regulations and the market, innovation in drug pipeline, portfolio management and business development, intellectual property protection and biosimilars.
Discussion On Counterfeits With A Flavour Of Rum At WTO TRIPS Council 06/06/2012 by Catherine Saez, Intellectual Property Watch 1 Comment Intellectual property enforcement was discussed at yesterday’s session of the World Trade Organization council on IP-related issues in two different contexts, both involving the United States. Cuba complained about the US failure to comply with a 10-year-old ruling on a Cuban rum brand name, and the US added an agenda item on enforcement against counterfeit goods, both of which created some stir.
European Nuclear Lab CERN Launches New “Easy IP” Plan 04/06/2012 by William New, Intellectual Property Watch 2 Comments Does the idea of a multifunctional, versatile position-sensitive detector for measuring characteristics of a beam of particles spark ideas for useful products of benefit to society and the economy? If so, then CERN has just the thing for you. In an attempt to boost the utility of its research, the European Organization for Nuclear Research (CERN), the Geneva-based intergovernmental laboratory, today announced a plan to offer its patented technologies for licence royalty-free in order to promote innovation.
Compulsory Licences Positive For The South, With Conditions, Study Finds 31/05/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment Compulsory licences can provide an efficient way to decrease prices of drugs in developing countries but the conditions of issuance of a licence influence the benefits countries can derive from them, particularly if the countries have a technology gap, according to an economic model presented this week at the World Intellectual Property Organization.
World Health Assembly: WHO Carves Out Leadership Role In “Vaccine Decade” 28/05/2012 by Rachel Marusak Hermann, Intellectual Property Watch Leave a Comment With a generous pledge and a grand vision, Bill Gates launched the “Decade of Vaccines” two years ago. By endorsing a “Global Vaccine Action Plan” during the World Health Assembly, the world’s health authority stands as the lead agency in advancing the initiative.
US, China To Hold Landmark Intellectual Property Adjudication Meeting 24/05/2012 by Maricel Estavillo for Intellectual Property Watch Leave a Comment The United States and China will hold early next week what is becoming the largest bilateral programme between their courts in the area of intellectual property adjudication. Set to gather more than a thousand participants, the discussions will largely revolve around patent litigation, according to a top US judge.
Group Looks At Effects Of America Invents Act On Plant Breeders 24/05/2012 by Intellectual Property Watch Leave a Comment CIOPORA, an international association of plant breeders, held its annual meeting recently with a focus on novelties in plant patents introduced by the America Invents Act, to become effective on 16 March 2013.
WHO Members To Address Proposals For Financing Developing Country R&D 22/05/2012 by William New, Intellectual Property Watch Leave a Comment Members of the World Health Organization at their annual meeting tomorrow will address proposals for ways to finance research and development for diseases which afflict mainly developing countries but for which there are not lucrative markets.
Nobel Laureate, Other Experts Hail WHO Effort On Medicines R&D Framework 22/05/2012 by William New, Intellectual Property Watch 1 Comment The annual World Health Assembly being held this week has a rare chance to achieve a breakthrough on health research for the global poor if it can agree to move forward on a proposed convention, proponents said at a recent meeting.